Showing posts with label diagnostics. Show all posts
Showing posts with label diagnostics. Show all posts

Tuesday, February 18, 2020

What are the latest trends in Point of Care (PoC) Diagnostics market?

The Global Point of Care (PoC) Diagnostics Market report evaluates the market size, share, revenue generation, and commercialization aspects to project the same for the forecast years by 2026. Furthermore, it also examines the existing competitive scenario with the individual standing of leading companies to project their growth in the coming years based on extensive company profiles and statistical approaches of the companies to realize their desired expansion objectives in the regional markets. The study delivers an extensive overview of the market, along with a summary of the leading participants in the global sector.

According to the current analysis of Reports and Data, the global Point of Care (PoC) Diagnostics market was valued at USD 23.98 Billion in 2018 and is expected to reach USD 50.51 Billion by year 2026, at a CAGR of 9.6%.
To view a Sample copy of the Point of Care (PoC) Diagnostics Market Report with a detailed TOC, visit @ https://www.reportsanddata.com/sample-enquiry-form/1507
Scope of the Report:
The research study draws focus on the strengths and weaknesses of the leading companies through an elaborate SWOT analysis and also inspects their evolution through an exhaustive historical analysis. Additionally, the global Point of Care (PoC) Diagnostics market report segments the industry based on products, applications, and regions. The investigation, supported by extensive research, performs a Porter’s Five Forces Analysis to predict the growth of the market. The study assesses the global sector in terms of size, share, and revenue. Furthermore, the report also scrutinizes the global Point of Care (PoC) Diagnostics market based on market share and consumer base in major geographies. It also assesses the growth of individual segments in the Global Point of Care (PoC) Diagnostics market over the forecast duration. The report focuses on the leading manufacturers in the industry and also evaluates the sales volume, market value, competitive scenario, market share, and development strategy for the forecast years.
Segmentation –
Key Players - Abbott,  AccuBioTech, BioMérieux SA, Bio-Rad Laboratories, Becton, Dickinson, and Company, Chembio Diagnostics, Danaher,  EKF Diagnostics, F. Hoffmann-La Roche, Instrumentation Laboratory, Johnson & Johnson, Nova, PTS Diagnostics, Sekisui Diagnostic, Siemens Healthineers, Sinocare Inc., Sysmex Corporation, Trinity Biotech, Trividia Health Inc., QIAGEN and Quidel.
Types - Glucose Monitoring Products, Strips, Meters, Lancets & Lancing Devices
Applications - Professional Diagnostic Centres, Clinical Laboratories (Outpatient Healthcare & Ambulatory Care Settings), Hospitals/Critical Care Centres, Home Care, Research Laboratories, Other End Users
Purchase the complete report at discounts like never before, visit @ https://www.reportsanddata.com/discount-enquiry-form/1507
The report gives an industry-wide analysis of the market scenario, supply and demand dynamics, sales, and production capacity. The study also reviews the rates of production and consumption, capacity, sales, gross revenue, import/export status, pricing structure, profit margin, and cost volatility. Overall, the report covers the Global Point of Care (PoC) Diagnostics market scenario and predicts its growth in the coming years. The study offers the reader extensive coverage of all relevant market aspects, including drivers, restraints, and other elements influencing the growth of the industry in the coming years. It is a one-stop solution for all the key players extending to the different aspects of the industry including various aspects like critical facts and figures, development history, and market share to help the readers formulate lucrative strategies for expansion.
The research study derives data from various regulatory organizations to evaluate the growth of every segment and evaluates the presence of the Point of Care (PoC) Diagnostics market in the major geographies. It inspects the macro- and micro-economic factors impacting the market growth in the regions included in the study. The global Point of Care (PoC) Diagnostics market has been categorized on the basis of the regions into Latin America, Asia Pacific, North America, Europe, and the Middle East & Africa.
Aims of the study:
  1. To offer a detailed analysis of the market scenario to derive a forecast for the major segments of the global Point of Care (PoC) Diagnostics market.
  2. To give accurate insights into the future of the market by assessing the factors influencing the market growth.
  3. To analyze different aspects of the Point of Care (PoC) Diagnostics market like cost analysis, supply chain analysis, Porter’s Five Forces analysis, and SWOT analysis, along with other analytical tools.
  4. To perform an elaborate historical analysis and forecast revenue of the market segments and sub-segments for the four key geographic regions and their countries i.e.., North America, Europe, Asia, Latin America and the Rest of the World.
  5. To carry out a country-level analysis of the industry to calculate the current market size and forecast the future market size.
  6. To provide a comprehensive analysis of the market segments based on applications, product types, regions, and sub-segments.
  7. To profile key strategies of leading players in the market, exhaustively evaluating their product range, capabilities, and highlighting the competitive landscape of the global market.
  8. To track and analyze the developments seen in the industry, such as joint ventures, strategic alliances, mergers and acquisitions, product innovation, product launches, and research and development into the global Point of Care (PoC) Diagnostics market.
To buy the complete Point of Care (PoC) Diagnostics Market Report, click here @ https://www.reportsanddata.com/checkout-form/1507

Friday, November 22, 2019

Blood Culture Tests Market To Reach USD 7060.5 Million By 2026 | Reports and Data

Market Size – USD 3857.6 Million in 2018, Market Growth - CAGR of 8.0 %, Market Trends – Product launches and research for advanced Blood culture test
According to the current analysis of Reports and Data, the global Blood culture test market was valued at USD 3857.3 Million in 2018 and is expected to reach USD 4768.9 million by year 2026, at a CAGR of 8.0%. The study covers in depth analysis of Blood culture tests and challenges faced by them. The blood culture represents a critical tool, for the healthcare professionals as a means of identifying the harmful presence of living organisms in the bloodstream. A positive blood culture can help to find a definitive diagnosis and enable the targeting therapy against the specific organism and provide prognostic value. False positives arising due to contamination, usual risks of venipuncture increasing use central venous catheters (CVC) and other indwelling vascular access devices and high costs are major hindrance to the global blood culture test. One of the biggest challenges faced during blood sample collection is making sure an organism is inadvertently introduced in the blood. Despite its limitations, the blood culture remains the “gold standard” for the detection of bacteremia.

Get a sample copy of this premium report @ https://www.reportsanddata.com/sample-enquiry-form/1461
Blood Culture Tests Market | Reports and Data
Further key findings from the report suggest
  • Blood culture tests are taken in number of suspected disease conditions which includes enteric fever, infective endocarditis, meningitis, pneumonia.
  • If your blood contains Microorganism, they will utilize (eat) the nutrient available in the broth and multiply. To make sure such organisms do not die appropriate media and incubation are used. Inoculated broth is incubated in an special instrument which has controlled environment i.e. Temperature-37°C (our body temperature), aeration, agitation. After 3-5 days the instrument will give signal about the presence of organism.
  • When these organisms grow in the above -mentioned media, they may make the changes in the media where they grow. Thus, lab professionals track such changes and the appearance of such organisms to identify them. Laboratory professionals use various techniques such as Gram Staining, study of morphological characteristics or Biochemical tests to identify them. Thus, finally being able to recognize which organism is present in your blood sample. Organism that cause disease to us and are frequently isolated from blood are:
  • Salmonella Typhi/Para Typhi
  • Staphylococcus aureus 
  • Streptococcus pneumoniae
  • Escherichia coli
  • Acinetobacter spp
  • Pseudomonas spp
  • Streptococcus pyogenes 
  • Enterococcus spp
  • The automated blood culture technique segment is anticipated to have highest CAGR during the forecast period owing to its technological advancements, increasing investments for the launch of new products.
  • Increasing demand for advanced diagnostic technologies, such as microarray, Polymerase Chain Reaction (PCR), and Peptide Nucleic Acid—Fluorescent In Situ Hybridization (PNA-FISH), is expected to propel the market growth
  • North America accounts for the largest share in the global blood culture tests accounting for 35.5% of the total market share.
  • Asia Pacific region is anticipated to grow at the highest CAGR because of advanced technology used in the medical sector, increasing demand for effective diagnostic techniques, various government initiatives awareness about the disease, availability of blood culture products in many regions. It accounts for 24.8% of the total market share in blood culture test.
  • On the basis of product, consumables (73.3 %) are expected to hold the highest share of the blood culture test market. In comparison to instruments, consumables are a popular option.
  • On the basis of technology, molecular technologies are anticipated to grow at the highest CAGR during the forecast period due to rapid increase in the incidence of sepsis.
  • Key players in the blood culture market include Thermo Fisher Scientific, Inc, Becton, Dickinson and Company, bioMérieux SA, Cepheid, Inc, Nanosphere, Inc., IRIDICA, Beckman Coulter, Bruker Corporation, and T2 Biosystems
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/blood-culture-tests-market
For the purpose of this study, Reports and Data have segmented the Blood culture test market on the basis of method, product, Instruments, technology, application, end use, and region:
Method (Revenue, USD Million; 2016–2026)
  • Conventional/Manual Blood Culture Method
  • Automated Blood Culture Method
Product (Revenue, USD Million; 2016–2026)
  • Consumables  
    • Blood Culture Media
      • Aerobic Blood Culture Media
      • Pediatric Blood Culture Media 
      • Anaerobic Blood Culture Media
      • Fungi/Yeast Blood Culture Media
      • Mycobacteria Blood Culture Media
  • Assay Kits and Reagents
  • Blood Culture Accessories   
Instruments (Revenue, USD Million; 2016–2026)
    • Automated Blood Culture Systems
    • Supporting Laboratory Equipment
      • Incubators
      • Colony Counters
      • Microscopes
      • Gram Stainers
      • Software & Services
 Technology (Revenue, USD Million; 2016–2026)
  • Culture-based Technology
  • Molecular Technology
    • Microarray
    • PCR
    • PNA-FISH
  • Proteomic Technology
 Application (Revenue, USD Million; 2016–2026)
  • Bacteremia
  • Fungemia
 End Use (Revenue, USD Million; 2016–2026)
  • Hospital Laboratories
  • Reference Laboratories
Make an inquiry before buying this report: https://www.reportsanddata.com/make-enquiry-form/1461
Regional Outlook (Revenue in USD Million; 2016–2026)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America
    • Brazil
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:
John Watson
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports  and Data | Web: www.reportsanddata.com

Histology and Cytology Market Insights, Industry Growth Prospectus and Regional Analysis by 2026

Market Size – USD 11,057.7 million in 2018, Market Growth - CAGR of 13.6%, Market Trends – Product launches and research for advanced Histology and Cytology
According to the recent analysis of Reports and Data, the global histology and cytology market was valued at USD 11,057.7 million in 2018 and is expected to reach USD 30,543.4 million by the year 2026, exhibiting a CAGR of 13.6%. Histology and Cytology procedures are related to the diagnosis of diseases and other conditions. Histology is the study of human tissues, which includes structure and function, whereas cytology is the study of human cells. Histology and cytology market had experienced a huge growth with regards to healthcare industries as several fatal diseases can be diagnosed through these clinical studies.
Currently, use of molecular techniques is a widely accepted method in histology and cytology as an enabler of morphology for diagnosing and prognosing. Moreover, the study of markers of therapeutic response has been helpful in some types of neoplasms for diagnosing cancer. There are numerous advantages in the use of cytological material to perform molecular studies: ease of obtaining fresh sample, ability to check the quality of the sample immediately after draw and better preservation of DNA and RNA.
Get a sample copy of this premium report @ https://www.reportsanddata.com/sample-enquiry-form/2194
Histology and Cytology Market | Reports and Data
The possibility of using genomic and proteomic research in small quantities of sample obtained by fine-needle aspiration (ENA) can minimize invasive procedures and allow the monitoring of cancer, thereby increasing the demand of histology and cytology procedures. PCR, microarrays, proteomic and other sequencing methodologies are now being validated in cytological samples. Proper specimen processing is of utmost importance in maintaining morphology and nucleic acid integrity. The role of the cytopathologist is mandatory in the collection and selection of cells. Histopathology evaluation basically compares diseased or experimentally altered tissues with matching sample from healthy or control counterparts. Therefore, it is very important to rigor-ously standardize every histology process (i.e., specimen sam-pling, trimming, embedding, sectioning, and staining). Cytology allows the identification of malignancy from a small quantity of cells. Cervical Pap smears are the most widely accepted example of this kind of testing and have dramatically reduced the incidence of  cervical carcinoma.
Cytology provides patients a minimally or non-invasive means of obtaining samples and allows analysis of samples such as exfoliated cells in sputum and urine, and pleural, pericardial, cyst  fluids. Fine needle aspiration provides cell samples from small lesions, and under image guidance from inaccessible sites such as the lung, head of pancreas and para-aortic lymph nodes. Specimens are often very small and to obtain maximum utility, the process should be performed by trained technicians and using proper and high-end cytology and histology equipment. Growing awareness about the screening of cancer and technological advancements in the cell and tissue studies are likely to boost the demand during the forecast period. An increasing number of well-equipped clinical laboratories in developing countries and favorable reimbursement for cancer screening and laboratory tests are likely to propel market growth. Advancements in cytology and histology save time for pathologists, making the service more cost-effective. Low cost, high sensitivity, and adequate specificity associated with cytology examination procedure will further bolster the histology and cytology market growth. Efficient testing of samples can result in cost-saving and faster outcomes to patients and increasing awareness of individuals about their health. Stringent regulation is one of the key factors for hampering the growth of histology and cytology market.
Further key findings from the report suggest
  • Histology and cytology market had experienced a huge growth in the healthcare industry as several fatal diseases can be diagnosed through these clinical studies
  • Roche launched the VENTANA DP 200 slide scanner which is a high-speed slide scanner for digital pathology in March 2018. It reduces workflow errors and improves image quality. Such product launches are expected to drive histology and cytology market
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/histology-and-cytology-market
  • Cytology testing attributed to large disease prevalence and adoption of the test for cervix screening. The segment can maintain its leading position during the forecast period due to the recent entry of various tests and advantages over histology such as faster analysis and cost-effectiveness
  • Flow Cytometry sub-segment was expected to show the maximum CAGR during the forecast period within the test type segmentation of the histology and cytology. This segment is used to detect and measure characteristics of cell mainly used in laboratories which contribute to the market growth of this product segment
  • The histology and cytology market will prove advantageous to the Asia-Pacific region to a great extent. It’s CAGR was the highest amongst all regions during the forecast period.The major factor driving the growth of this market is the huge population density in countries like India and China and increasing awareness about these tests
  • In September 2018, Phillips launched computational pathology software, Tissue Mark, for automated ovarian and prostate tumor detection, which provides doctors and lab technicians with an effective histology and cytology diagnosis tool
  • Some of the key players operating in the histology and cytology market are Abbott Laboratories; Becton Dickinson and Company; BrandTech Scientific, Hoffmann-La Roche Ltd.; Hologic, Inc.; Life Technologies Corporation; Sysmex Corporation; Thermo Fisher Scientific, Inc.; Southwest Precision Instruments, and Trivitron Healthcare
For this report, Reports and Data have segmented the Histology and cytology market based on type, disease type, treatment type, test type, end-use and region:
Type of Examination in Histology and Cytology market (Revenue, USD Million; 2016–2026)
  • Cytology
    • Cervical Cancer
    • Breast Cancer
    • Other Cancers
  • Histology
Test Type in Histology and Cytology market (Revenue, USD Million; 2016–2026)
  • Microscopy methods
    • Cytochemistry and histochemistry
    • Immunohistochemistry and Immunofluorescence
  • Flow cytometry
  • Molecular genetic methods
    • Cytogenic tests
      • karyotyping
      • fluorescent in situ hybridization (FISH)
    • Polymerase chain reaction
    • Others
End-use of Histology and Cytology market (Revenue, USD Million; 2016–2026)
  • Hospitals/Clinics
  • Biopharmaceuticals companies
  • Academia
  • Other end-users
Make an inquiry before buying this report @ https://www.reportsanddata.com/make-enquiry-form/2194
Regional Outlook of Histology and Cytology market (Revenue in USD Million; 2016–2026)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:
John Watson
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports  and Data | Web: www.reportsanddata.com

Thursday, November 21, 2019

Nucleic Acid Amplification Testing (NAAT) Market Is Expected To Reach USD 4.549 Billion By 2026


Market Size – USD 2.315 Billion in 2018, Market Growth - CAGR of 8.8%, Market Trends – Product launches and research for advanced Nucleic Acid Amplification Testing
According to the current analysis of Reports and Data, the global Nucleic Acid Amplification Testing (NAAT) market was valued at USD 2.315 Billion in 2018 and is expected to reach USD 4.549 Billion by year 2026, at a CAGR of 8.8 %. The study covers Nucleic acid which a complex organic substance essential to all forms of life. It is present in living cells as RNA and DNA, composed of nucleotides linked in a long chain. Whereas, Nucleic acid amplification testing is a method of testing the blood to detect pathogen causing bacteria or virus in in blood, tissue, urine, etc.
The nucleic acid amplification testing is widely used in the field of diagnostics. With market players exploring the applications of nucleic acid amplification testing, and it is expected to be adopted in new disease fields for the diagnostics and monitoring purpose. For instance, Gen-Probe, Inc., a US based Clinical Diagnostics company, introduced three assays based on its transcription-mediated amplification technology: the APTIMA CT assay (ACT), which detects C. trachomatis, the APTIMA GC assay (AGC), which detects Neisseria gonorrhoeae, and the APTIMA COMBO 2 assay (AC2), which detects both pathogens.

Request for FREE sample of this premium report @ https://www.reportsanddata.com/sample-enquiry-form/2187
Nucleic Acid Amplification Testing (NAAT) Market | Reports and Data
Increasing need for advanced diagnostic methods, wide range of applications in identification and monitoring of numerous diseases, increasing investment in the diagnostics sector, initiatives by governments all over the globe, extensive range of uses, growing demand from blood banks and transfusion centers, technological development in healthcare sector, are some of the prominent factors propelling nucleic acid amplification testing market growth in the industry.
However, associated safety concerns related to the nucleic acid amplification testing process, and dearth of sophisticated infrastructure essential for these kind of advanced technology in some developing nations, are the major hindrances restraining the nucleic acid amplification testing market growth during 2019-2026.
Further key findings from the report suggest
  • Nucleic Acid Amplification testing market is growing at a CAGR of 8 % in Asia Pacific followed by North America and Europe, with 8.6 % and 8.5 % CAGR, respectively. Growing demand for the advanced diagnostic measures the globe is the prominent factor to accelerate the nucleic acid amplification testing market growth during forecast period across all regions
  • As of 2018, Target Amplification system is the dominating Nucleic Acid Amplification Testing technique which holds 38.8 % of the global market. North America regional market is the chief revenue generating source for this product segment, followed by Europe and Asia-Pacific regions.
  • Probe amplification systems is expected to grow at a CAGR of 8.4 %. The market segment will reach USD 1.5 Billion mark by 2026.
  • Infectious disease application type segment was valued at USD 1.03 billion and is expected reach USD 1.97 billion by 2026, growing at a CAGR of 8.7%.
  • Asia Pacific is expected to account for the 22.5 % of the global Nucleic Acid Amplification Testing market. Developing nations such China, and India are likely to witness significant growth
  • Associated safety concerns related to the nucleic acid amplification testing process and dearth of sophisticated infrastructure essential for these kind of advanced technology is likely to hinder the nucleic acid amplification testing market growth during the forecast period
  • Key participants include Siemens Healthcare GmbH, Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd, Grifols SA, Becton, Illumina Inc., Dickinson and Company, Beckman Coulter Inc., Bio-Rad Laboratories, and bioMrieux SA
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/nucleic-acid-amplification-testing-naat-market
Segments covered in the report
This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2016 to 2026. For the purpose of this study, Reports and Data have segmented the Nucleic Acid Amplification Testing market on the basis of Technique type, Application type, and region:
Technique Type (Revenue, USD Million; 2016–2026)
  • Target Amplification
  • Probe Amplification
  • Signal Amplification
Application Type (Revenue, USD Million; 2016–2026)
  • Infectious Diseases
  • Cancer
  • Personalized Medicine
  • Genetic
Regional Outlook (Revenue in USD Million; 2016–2026)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Benelux
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Egypt
    • Israel
    • Rest of MEA
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.


Contact Us:
John Watson
Head of Business Development
Direct Line: +1-212-710-1370 
Reports  and Data | Web: www.reportsanddata.com


The Alarming Increase in Incidences of Stroke is Boosting the Adoption of Neurovascular Devices

Neurovascular disorders are the second most leading causes of death worldwide after heart diseases. Statistical data suggest a high number o...